
Sensus Healthcare, Inc.
SRTSNasdaqCIK 1494891HealthcareFiscal year ends Dec 31
Reports and events: 141 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-2314:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-022355 |
| 2023-02-0916:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-009738 |
| 2023-01-0917:00 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-23-001717 |
| 2022-11-1014:22 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-071048 |
| 2022-11-0316:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-068983 |
| 2022-08-1213:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-047246 |
| 2022-08-0416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-044758 |
| 2022-06-0909:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-22-031850 |
| 2022-05-1216:23 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-025962 |
| 2022-05-0516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-024232 |
| 2022-04-2909:54 ET | DEF 14A | Proxy statementPeriod 2022-06-03 | 0001213900-22-022569 |
| 2022-03-2516:03 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-015172 |
| 2022-03-0911:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-011247 |
| 2022-03-0313:35 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-22-010531 |
| 2022-02-1016:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-006461 |
| 2022-01-3116:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-22-004504 |
| 2022-01-0514:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-000684 |
| 2021-11-1014:23 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-058065 |
| 2021-11-0416:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-056757 |
| 2021-08-1310:09 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-042324 |
| 2021-08-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-040518 |
| 2021-06-0416:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-21-030969 |
| 2021-05-1412:19 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-026314 |
| 2021-05-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-024891 |
| 2021-04-3012:42 ET | DEF 14A | Proxy statementPeriod 2021-06-04 | 0001213900-21-023754 |
| 2021-03-0512:58 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-013664 |
| 2021-02-2516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-011631 |
| 2020-11-1013:44 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-036128 |
| 2020-11-0517:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-20-035347 |
| 2020-11-0516:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-20-035289 |
| 2020-10-0217:32 ET | 10-K/A | Annual report, amendedPeriod 2019-12-31 | 0001213900-20-029646 |
| 2020-08-1014:10 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001213900-20-021119 |
| 2020-08-0616:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-20-020649 |
| 2020-08-0414:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-020126 |
| 2020-06-0511:58 ET | 8-K | 5.07 Shareholder vote results | 0001213900-20-014183 |
| 2020-06-0106:02 ET | 8-K | 8.01 Other events | 0001213900-20-013749 |
| 2020-05-1115:25 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001213900-20-011609 |
| 2020-05-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-20-011290 |
| 2020-04-2916:10 ET | DEF 14A | Proxy statementPeriod 2020-06-05 | 0001213900-20-010436 |
| 2020-03-0616:23 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001213900-20-005609 |
| 2020-02-1316:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-20-003574 |
| 2020-01-1016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-20-000756 |
| 2019-11-0811:01 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001213900-19-022496 |
| 2019-11-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-19-022198 |
| 2019-08-1215:24 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001213900-19-015316 |
| 2019-08-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-19-014955 |
| 2019-06-0717:08 ET | 8-K | 5.07 Shareholder vote results | 0001213900-19-010341 |
| 2019-06-0408:33 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615774-19-009097 |
| 2019-05-1413:29 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001615774-19-007745 |
| 2019-05-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001615774-19-007378 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 13:10 ET. Listed shows no prices and gives no investment advice.